[Treatment of atherosclerosis by pyridinolcarbamate. Review of the history of the introduction of pyridinolcarbamate and its clinical results].
D000328:Adult; D000368:Aged; D000818:Animals; D001011:Aorta / Q000032:analysis / Q000473:pathology; D001161:Arteriosclerosis / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D002196:Capillaries / Q000473:pathology; D002219:Carbamates / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D002784:Cholesterol / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use; D011817:Rabbits; D011859:Radiography; D013927:Thrombosis / Q000188:drug therapy
D002219:Carbamates; D011725:Pyridines; D002784:Cholesterol
Le traitement de l'athérosclérose par le pyridinolcarbamate. Revue de l'historique de l'introduction du pyridinolcarbamate et des résultats cliniques.